Tj Biopharma Co., Ltd.
Clinical trials sponsored by Tj Biopharma Co., Ltd., explained in plain language.
-
New drug duo aims to tackle Hard-to-Treat cancers
Disease control CompletedThis study tested a new drug called TJ004309, either alone or combined with another drug called Toripalimab, in 225 adults with advanced solid tumors that had stopped responding to standard treatments. The goal was to find the safest dose and see early signs of effectiveness. The…
Phase: PHASE1, PHASE2 • Sponsor: TJ Biopharma Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 12:33 UTC
-
Healthy men test two versions of TJ101 injection for similarity
Knowledge-focused CompletedThis study checks whether a new version of TJ101 injection works the same as the old version in 96 healthy Chinese men. Each man gets one dose of each version, and researchers measure drug levels in the blood. The goal is to see if the two are bioequivalent, not to treat any dise…
Phase: PHASE1 • Sponsor: TJ Biopharma Co., Ltd. • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:03 UTC